教學方式：
<br>
<br>Lecture, oral presentation, midterm and final examinations.
<br>
<br>學習評量：
<br>
<br>Midterm 					35%
<br>Final exam 					35%
<br>Oral Presentation				20%
<br>Attendance and questions 	 	        10%
<br>
<br>
<br>Oral Presentation (Topic: case study) 12 組
<br>
<br>Week 1	Basic Principles I (Ch 1)
<br>Week 2	Basic Principles II (Ch5)
<br>Week 3	Autonomic System (Ch 10)
<br>Week 4	Cardiovascular-Renal Drugs (Ch 13)
<br>Week 5	Drugs with important actions on smooth muscle (Ch 20)
<br>Week 6	Drugs used to treat diseases of inflammation (Ch 36)
<br>Week 7	Drugs used to treat diseases of blood (Ch34)
<br>Week 8  Midterm
<br>Week 9	Endocrine Drugs (Ch 41)
<br>Week 10	Anti-infectious Drugs I (Ch 43)
<br>Week 11	Anti-infectious Drugs II (Ch 49)
<br>Week 12 Drugs that act in the CNS-I
<br>Week 13 Drugs that act in the CNS-II
<br>Week 14 Cancer Drugs 
<br>Week 15 Drug Discovery and Development
<br>Week 16 Final
<br>
<br>基於透明與負責任的原則，本課程鼓勵學生利用AI進行協作或互學，以提升本門課產出品質。根據本校
<br>公布之「大學教育場域AI協作、共學與素養培養指引」，本門課程採取有條件開放，以下說明如何使用
<br>生成式AI於課程產出
<br>
<br>學生須於課堂作業或報告中的「標題頁註腳」或「引用文獻後」簡要說明如何使用生成式AI進行議題發
<br>想、文句潤飾或結構參考等使用方式。若經查核使用卻無在作業或報告中標明，教師、學校或相關單位
<br>有權重新針對作業或報告重新評分或不予計分。本門課授課教材或學習資料若有引用自生成式AI，教師
<br>也將在投影片或口頭標注。修讀本課程之學生於選課時視為同意以上倫理聲明。
<br>
<br>
<br>